ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2025, ICU Medical (ICUI) reported revenue of $535.94 million, down 13.8% over the same period last year. EPS came in at $1.91, compared to $2.11 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $528.97 million, representing a surprise of +1.32%. The company delivered an EPS surprise of +13.52%, with the consensus EPS estimate being $1.68.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how ICU Medical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Infusion Systems: $176.3 million compared to the $177.59 million average estimate based on two analysts.Revenue- Vital Care: $79.7 million compared to the $76.87 million average estimate based on two analysts.Revenue- Consumables: $284.7 million versus the two-analyst average estimate of $280.64 million.View all Key Company Metrics for ICU Medical here>>>Shares of ICU Medical have returned -2.3% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ICU Medical, Inc. (ICUI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks